Therapeutic Goods Act 1989
I, MICHAEL DODSON, A/g Head, Office of Non-prescription Medicines, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of section 42 DK (I) of the Therapeutic Goods Act 1989, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use ofthe therapeutic goods described in paragraph (b) below, may be included either on the label of the package of those goods or in information included in the package in which those goods are contained:
- representations to the effect that the goods described in paragraph (b) below may be used "For the treatment of patients with known cardiovascular or cerebrovascular disease, as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)" and "inhibits blood clotting and reduces the risk of heart attack and stroke in patients with known cardiovascular or cerebrovascular disease".
- TIANDA ASPIRIN 100mg ENTERIC COATED LOW DOSE ASPIRIN tablet blister pack AUST R 171351.
- supplied as an over-the-counter drug by Tianda Pharmaceuticals Pty Ltd.
Dated this 26th day of May 2010.
MICHAEL DODSON
Delegate ofthe Secretary to the Department of Health and Ageing